US based
- World
SII partner Novavax’s COVID-19 shot 90% effective
Washington: US-based biotechnology company Novavax’s protein-based vaccine has shown overall 90 per cent efficacy against Covid-19, results of Phase-3 trials have shown. The vaccine NVX-CoV2373 is already being locally manufactured by the company’s…
- Hyderabad
Funded by Palakurthi Foundation, Vision-Aid sets up CoE in Hyderabad
Hyderabad: Supported by US-based Palakurthi Foundation, Vision-Aid, an organisation working in the field of vision-related disabilities has announced the creation of a new Centre of Excellence (CoE) in partnership with LV Prasad…
